A Single Center, Non-randomized Phase IIa Study of Abraxane in Combination With Cisplatin in Advanced Nasopharyngeal Carcinoma

Trial Profile

A Single Center, Non-randomized Phase IIa Study of Abraxane in Combination With Cisplatin in Advanced Nasopharyngeal Carcinoma

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
  • Indications Nasopharyngeal cancer
  • Focus Adverse reactions
  • Acronyms ABX-DDP-Dose
  • Most Recent Events

    • 06 Dec 2013 Planned End Date changed from 1 Aug 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
    • 04 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top